Overview
A multiple ascending dose phase I study of ICP-332 in healthy subjects
Eligibility
Inclusion Criteria:
- Voluntarily sign the informed consent form
- Body mass index (BMI) of ≥ 18.5 kg/m2 and < 30 kg/m2
- Male or infertile female subjects who are between 18-55 years old (inclusive)
Exclusion Criteria:
- Significant current or past acute or chronic disease or condition.
- A history of tuberculosis or current active/latent infection.
- With a history of drug or food allergy, or allergy to any of the composition components of the study drug, or allergic disease.
- Subjects with clinically significant abnormalities in the screening examinations.